中国癌症杂志 ›› 2017, Vol. 27 ›› Issue (4): 241-250.doi: 10.19401/j.cnki.1007-3639.2017.04.001

• 专家述评 • 上一篇    下一篇

2016年胰腺癌研究及诊疗进展

梁丁孔,施 思,徐 近,虞先濬   

  1. 复旦大学附属肿瘤医院胰腺外科,复旦大学胰腺肿瘤研究所,
    复旦大学上海医学院肿瘤学系,上海 200032
  • 出版日期:2017-04-30 发布日期:2017-05-05
  • 通信作者: 虞先濬 E-mail: yuxianjun@fudanpci.org
  • 基金资助:
    国家杰出青年科学基金(81625016);上海市青年科技英才杨帆计划(17YF1402500)。

Recent advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2016

LIANG Dingkong, SHI Si, XU Jin, YU Xianjun   

  1. Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Published:2017-04-30 Online:2017-05-05
  • Contact: YU Xianjun E-mail: yuxianjun@fudanpci.org

摘要: 胰腺癌是消化系统恶性程度最高的肿瘤之一,病情进展快,预后极差。近年来,发病率亦明显升高。胰腺癌的治疗模式已由单纯的手术优先,走向包括外科手术、化学治疗和放射治疗等在内的多学科综合治疗,其临床疗效有了明显提高。近年来,随着对胰腺癌发生、发展机制研究的不断深入,研究者对疾病本身有了更加清晰的认识,也为基础临床的转化提供了线索。该研究参考2016年国内外发表的胰腺癌基础和临床研究相关文献,针对胰腺癌发病因素、基础研究热点、外科手术相关进展及化学治疗进展等方面进行综述。

关键词: 胰腺癌, 流行病学, 基础研究, 临床研究, 进展

Abstract: Pancreatic cancer is a highly malignant, fast progressive digestive system neoplasm with poor prognosis, and the incidence has increased significantly in the recent years. The treatment mode of pancreatic cancer has been transformed from surgery-first approach to multidisciplinary approach including surgery, chemotherapy, radiotherapy and other comprehensive treatment modalities, accompanying with significant improvement in clinical efficacy. During the last decade, the molecular mechanism of pancreatic cancer has been explored in depth. Indeed, we had a clearer understanding of the disease, which provides clues for translation of basic research into clinical practice. This review summarized recent high quality studies on pancreatic cancer including pathogenic factor, advances in basic research, and clinical treatment.

Key words: Pancreatic cancer, Epidemiology, Basic research, Clinical research, Progress